Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,651 | -19,993 | -8,783 | -33,643 | -23,011 |
| Depreciation Amortization | 2,447 | 1,561 | 772 | 2,844 | 2,045 |
| Accounts receivable | 151 | 731 | 283 | -2,390 | -1,885 |
| Accounts payable and accrued liabilities | -318 | -501 | -449 | 1,343 | 570 |
| Other Working Capital | -23 | 1,507 | 19 | -2,072 | -2,626 |
| Other Operating Activity | 5,162 | 3,176 | 1,774 | 10,122 | 7,407 |
| Operating Cash Flow | $-22,232 | $-13,519 | $-6,384 | $-23,796 | $-17,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,693 | 6,747 | -290 | -67,997 | -47,791 |
| PPE Investments | -3,699 | -2,626 | -1,149 | -4,270 | -3,273 |
| Purchase Sale Intangibles | -350 | 0 | 0 | -882 | -888 |
| Other Investing Activity | -350 | 0 | 0 | -297 | -303 |
| Investing Cash Flow | $11,644 | $4,121 | $-1,439 | $-72,564 | $-51,367 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | 166 | 166 |
| Debt Repayment | -51 | -46 | -42 | -766 | -706 |
| Common Stock Issued | 574 | 553 | 25 | 86,943 | 86,611 |
| Other Financing Activity | 0 | 0 | 0 | -5,510 | -5,180 |
| Financing Cash Flow | $523 | $507 | $-17 | $80,833 | $80,891 |
| Beginning Cash Position | 35,723 | 35,723 | 35,723 | 51,250 | 51,250 |
| End Cash Position | 25,658 | 26,832 | 27,883 | 35,723 | 63,274 |
| Net Cash Flow | $-10,065 | $-8,891 | $-7,840 | $-15,527 | $12,024 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,232 | -13,519 | -6,384 | -23,796 | -17,500 |
| Capital Expenditure | -3,699 | -2,626 | -1,149 | -4,270 | -3,273 |
| Free Cash Flow | -25,931 | -16,145 | -7,533 | -28,066 | -20,773 |